HOLOGIC INC (HOLX)

US4364401012 - Common Stock

81.15  -0.42 (-0.51%)

After market: 81.15 0 (0%)

Fundamental Rating

6

Taking everything into account, HOLX scores 6 out of 10 in our fundamental rating. HOLX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HOLX is valued correctly, but it does not seem to be growing.



8

1. Profitability

1.1 Basic Checks

In the past year HOLX was profitable.
HOLX had a positive operating cash flow in the past year.
Of the past 5 years HOLX 4 years were profitable.
Each year in the past 5 years HOLX had a positive operating cash flow.

1.2 Ratios

HOLX's Return On Assets of 7.89% is amongst the best of the industry. HOLX outperforms 89.25% of its industry peers.
HOLX has a Return On Equity of 14.17%. This is amongst the best in the industry. HOLX outperforms 90.32% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.74%, HOLX belongs to the top of the industry, outperforming 88.17% of the companies in the same industry.
HOLX had an Average Return On Invested Capital over the past 3 years of 16.15%. This is significantly above the industry average of 8.19%.
The 3 year average ROIC (16.15%) for HOLX is well above the current ROIC(8.74%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.89%
ROE 14.17%
ROIC 8.74%
ROA(3y)13.44%
ROA(5y)10.53%
ROE(3y)26.72%
ROE(5y)22.35%
ROIC(3y)16.15%
ROIC(5y)14.15%

1.3 Margins

With an excellent Profit Margin value of 17.59%, HOLX belongs to the best of the industry, outperforming 93.01% of the companies in the same industry.
HOLX's Profit Margin has declined in the last couple of years.
The Operating Margin of HOLX (23.14%) is better than 94.62% of its industry peers.
HOLX's Operating Margin has improved in the last couple of years.
The Gross Margin of HOLX (55.41%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of HOLX has remained more or less at the same level.
Industry RankSector Rank
OM 23.14%
PM (TTM) 17.59%
GM 55.41%
OM growth 3Y-8.49%
OM growth 5Y8.14%
PM growth 3Y-27.37%
PM growth 5YN/A
GM growth 3Y-2.18%
GM growth 5Y1.16%

8

2. Health

2.1 Basic Checks

HOLX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
HOLX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOLX has less shares outstanding
The debt/assets ratio for HOLX has been reduced compared to a year ago.

2.2 Solvency

HOLX has an Altman-Z score of 4.49. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.49, HOLX is doing good in the industry, outperforming 72.04% of the companies in the same industry.
HOLX has a debt to FCF ratio of 2.52. This is a good value and a sign of high solvency as HOLX would need 2.52 years to pay back of all of its debts.
HOLX has a Debt to FCF ratio of 2.52. This is amongst the best in the industry. HOLX outperforms 88.17% of its industry peers.
HOLX has a Debt/Equity ratio of 0.51. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a worse Debt to Equity ratio (0.51) than 64.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 2.52
Altman-Z 4.49
ROIC/WACC1.04
WACC8.38%

2.3 Liquidity

A Current Ratio of 3.99 indicates that HOLX has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.99, HOLX is doing good in the industry, outperforming 62.90% of the companies in the same industry.
A Quick Ratio of 3.32 indicates that HOLX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.32, HOLX is doing good in the industry, outperforming 65.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.99
Quick Ratio 3.32

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.06% over the past year.
The Earnings Per Share has been growing by 12.01% on average over the past years. This is quite good.
Looking at the last year, HOLX shows a decrease in Revenue. The Revenue has decreased by -1.26% in the last year.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.61% yearly.
EPS 1Y (TTM)2.06%
EPS 3Y-0.42%
EPS 5Y12.01%
EPS Q2Q%13.98%
Revenue 1Y (TTM)-1.26%
Revenue growth 3Y2.19%
Revenue growth 5Y4.61%
Sales Q2Q%2.74%

3.2 Future

The Earnings Per Share is expected to grow by 7.31% on average over the next years.
Based on estimates for the next years, HOLX will show a small growth in Revenue. The Revenue will grow by 4.64% on average per year.
EPS Next Y5.34%
EPS Next 2Y7.01%
EPS Next 3Y7.68%
EPS Next 5Y7.31%
Revenue Next Year-0.07%
Revenue Next 2Y2.56%
Revenue Next 3Y3.58%
Revenue Next 5Y4.64%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.49, HOLX is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 84.95% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 31.46. HOLX is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 17.94, the valuation of HOLX can be described as rather expensive.
HOLX's Price/Forward Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 87.63% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, HOLX is valued a bit cheaper.
Industry RankSector Rank
PE 20.49
Fwd PE 17.94

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOLX is valued cheaper than 86.02% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 90.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.58
EV/EBITDA 15.39

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)3.84
PEG (5Y)1.71
EPS Next 2Y7.01%
EPS Next 3Y7.68%

0

5. Dividend

5.1 Amount

No dividends for HOLX!.
Industry RankSector Rank
Dividend Yield N/A

HOLOGIC INC

NASDAQ:HOLX (10/21/2024, 8:19:23 PM)

After market: 81.15 0 (0%)

81.15

-0.42 (-0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.85B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.49
Fwd PE 17.94
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.84
PEG (5Y)1.71
Profitability
Industry RankSector Rank
ROA 7.89%
ROE 14.17%
ROCE
ROIC
ROICexc
ROICexgc
OM 23.14%
PM (TTM) 17.59%
GM 55.41%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.99
Quick Ratio 3.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)2.06%
EPS 3Y-0.42%
EPS 5Y
EPS Q2Q%
EPS Next Y5.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.26%
Revenue growth 3Y2.19%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y